In Lyme borreliosis, the skin is the key site of bacterial inoculation by the infected tick, and of cutaneous manifestations, erythema migrans and acrodermatitis chronica atrophicans. We explored the role of fibroblasts, the resident cells of the dermis, in the development of the disease. Using microarray experiments, we compared the inflammation of fibroblasts induced by three strains of Borrelia burgdorferi sensu stricto isolated from different environments and stages of Lyme disease: N40 (tick), Pbre (erythema migrans) and 1408 (acrodermatitis chronica atrophicans). The three strains exhibited a similar profile of inflammation with strong induction of chemokines (CXCL1 and IL-8) and IL-6 cytokine mainly involved in the chemoattraction of immune cells. Molecules such as TNF-alpha and NF-κB factors, metalloproteinases (MMP-1, -3 and -12) and superoxide dismutase (SOD2), also described in inflammatory and cellular events, were up-regulated. In addition, we showed that tick salivary gland extracts induce a cytotoxic effect on fibroblasts and that OspC, essential in the transmission of Borrelia to the vertebrate host, was not responsible for the secretion of inflammatory molecules by fibroblasts. Tick saliva components could facilitate the early transmission of the disease to the site of injury creating a feeding pit. Later in the development of the disease, Borrelia would intensively multiply in the skin and further disseminate to distant organs.
References
[1]
Piesman J, Gern L (2004) Lyme borreliosis in Europe and North America. Parasitology 129:
[2]
Steere AC, Coburn J, Glickstein L (2004) The emergence of Lyme disease. J Clin Invest 113: 1093–1101.
[3]
van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, et al. (1993) Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 17: 708–717.
[4]
Müllegger RR, Glatz M (2008) Skin manifestations of Lyme borreliosis: diagnosis and management. Am J Clin Dermatol 9: 355–368.
[5]
Strle F, Stanek G (2009) Clinical manifestations and diagnosis of lyme borreliosis. In: Lipsker D, Jaulhac B, editors. pp. 51–110. Basel: Karger.
[6]
Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 17: 1063–1072.
[7]
Sorrell JM, Caplan AI (2004) Fibroblast heterogeneity: more than skin deep. J Cell Sci 117: 667–675.
[8]
Sorrell JM, Caplan AI (2009) Fibroblasts–a diverse population at the center of it all. Int Rev Cell Mol Biol 276: 161–214.
[9]
Saalbach A, Klein C, Sleeman J, Sack U, Kauer F, et al. (2007) Dermal fibroblasts induce maturation of dendritic cells. J Immunol 178: 4966–4974.
[10]
Filgueira L, Nestle FO, Rittig M, Joller HI, Groscurth P (1996) Human dendritic cells phagocytose and process Borrelia burgdorferi. J Immunol 157: 2998–3005.
[11]
Suhonen J, Komi J, Soukka J, Lassila O, Viljanen MK (2003) Interaction between Borrelia burgdorferi and immature human dendritic cells. Scand J Immunol 58: 67–75.
Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S (1997) Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol 158: 3285–3292.
[14]
Marchal C, Schramm F, Kern A, Luft BJ, Yang X, et al. (2011) Antialarmin effect of tick saliva during the transmission of Lyme disease. Infect Immun 79: 774–785.
[15]
Marchal CM, Luft BJ, Yang X, Sibilia J, Jaulhac B, et al. (2009) Defensin is suppressed by tick salivary gland extract during the in vitro interaction of resident skin cells with Borrelia burgdorferi. J Invest Dermatol 129: 2515–2517.
[16]
Wu J, Weening EH, Faske JB, Hook M, Skare JT (2011) Invasion of eukaryotic cells by Borrelia burgdorferi requires β1 integrins and Src kinase activity. Infect Immun 79: 1338–1348.
[17]
Castelli E, Caputo V, Morello V, Tomasino RM (2008) Local reactions to tick bites. Am J Dermatopathol 30: 241–248.
[18]
Grimm D, Tilly K, Byram R, Stewart PE, Krum JG, et al. (2004) Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci U S A 101: 3142–3147.
[19]
Tilly K, Krum JG, Bestor A, Jewett MW, Grimm D, et al. (2006) Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun 74: 3554–3564.
[20]
Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A (2011) Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res 343: 237–249.
[21]
Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, et al. (2004) Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313: 856–862.
[22]
Hovius JW (2009) Spitting image: tick saliva assists the causative agent of Lyme disease in evading host skin's innate immune response. J Invest Dermatol 129: 2337–2339.
[23]
Hovius JW, Levi M, Fikrig E (2008) Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med 5: e43.
[24]
Fikrig E, Narasimhan S (2006) Borrelia burgdorferi–traveling incognito ? Microbes Infect 8: 1390–1399.
[25]
Parsonage G, Filer AD, Haworth O, Nash GB, Rainger GE, et al. (2005) A stromal address code defined by fibroblasts. Trends Immunol 26: 150–156.
[26]
Jones NC, Germain A, Riley KE, Bautista C, Taylor W, et al. (1994) Borrelia burgdorferi decreases hyaluronan synthesis but increases IL-6 production by fibroblasts. Microb Pathog 16: 261–267.
[27]
Müllegger RR, Means TK, Shin JJ, Lee M, Jones KL, et al. (2007) Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma. Infect Immun 75: 4621–4628.
[28]
de Koning J (1993) Histopathologic patterns of erythema migrans and borrelial lymphocytoma. Clin Dermatol 11: 377–383.
[29]
de Koning J, Tazelaar DJ, Hoogkamp-Korstanje JA, Elema JD (1995) Acrodermatitis chronica atrophicans: a light and electron microscopic study. J Cutan Pathol 22: 23–32.
[30]
Aberer E, Klade H, Hobisch G (1991) A clinical, histological, and immunohistochemical comparison of acrodermatitis chronica atrophicans and morphea. Am J Dermatopathol 13: 334–341.
[31]
Lin B, Kidder JM, Noring R, Steere AC, Klempner MS, et al. (2001) Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. J Infect Dis 184: 174–180.
[32]
Hu LT, Eskildsen MA, Masgala C, Steere AC, Arner EC, et al. (2001) Host metalloproteinases in Lyme arthritis. Arthritis Rheum 44: 1401–1410.
[33]
Behera AK, Thorpe CM, Kidder JM, Smith W, Hildebrand E, et al. (2004) Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways. Infect Immun 72: 2864–2871.
[34]
Gronski TJ Jr, Martin RL, Kobayashi DK, Walsh BC, Holman MC, et al. (1997) Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem 272: 12189–12194.
[35]
Hartiala P, Hytonen J, Pelkonen J, Kimppa K, West A, et al. (2007) Transcriptional response of human dendritic cells to Borrelia garinii–defective CD38 and CCR7 expression detected. J Leukoc Biol 82: 33–43.
[36]
Salazar JC, Duhnam-Ems S, La Vake C, Cruz AR, Moore MW, et al. (2009) Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-β. PLoS Pathog 5: e1000444.
[37]
Petzke MM, Brooks A, Krupna MA, Mordue D, Schwartz I (2009) Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol 183: 5279–5292.
[38]
Suhonen J, Hartiala K, Tuominen-Gustafsson H, Viljanen MK (2000) Borrelia burgdorferi–induced oxidative burst, calcium mobilization, and phagocytosis of human neutrophils are complement dependent. J Infect Dis 181: 195–202.
[39]
Cinco M, Murgia R, Perticarari S, Presani G (1994) Simultaneous measurement by flow cytometry of phagocytosis and metabolic burst induced in phagocytic cells in whole blood by Borrelia burgdorferi. FEMS Microbiol Lett 122: 187–193.
[40]
Pancewicz SA, Skrzydlewska E, Hermanowska-Szpakowicz T, Zajkowska JM, Kondrusik M (2001) Role of reactive oxygen species (ROS) in patients with erythema migrans, an early manifestation of Lyme borreliosis. Med Sci Monit 7: 1230–1235.
[41]
Skaleric U, Manthey CM, Mergenhagen SE, Gaspirc B, Wahl SM (2000) Superoxide release and superoxide dismutase expression by human gingival fibroblasts. Eur J Oral Sci 108: 130–135.
[42]
Smetanick MT, Zellis SL, Ermolovich T (2010) Acrodermatitis chronica atrophicans: a case report and review of the literature. Cutis 85: 247–252.
[43]
Picken RN, Strle F, Picken MM, Ruzic-Sabljic E, Maraspin V, et al. (1998) Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions. J Invest Dermatol 110: 211–214.
[44]
Schwan TG, Piesman J (2000) Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol 38: 382–388.
[45]
Antonara S, Ristow L, McCarthy J, Coburn J (2010) Effect of Borrelia burgdorferi OspC at the site of inoculation in mouse skin. Infect Immun 78: 4723–4733.
[46]
Pal U, Yang X, Chen M, Bockenstedt LK, Anderson JF, et al. (2004) OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 113: 220–230.
[47]
Fikrig E, Feng W, Barthold SW, Telford SR, 3rd, Flavell RA (2000) Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol 164: 5344–5351.
[48]
Liang FT, Brown EL, Wang T, Iozzo RV, Fikrig E (2004) Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 165: 977–985.
[49]
Seshu J, Esteve-Gassent MD, Labandeira-Rey M, Kim JH, Trzeciakowski JP, et al. (2006) Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol Microbiol 59: 1591–1601.
[50]
LaFrance ME, Pierce JV, Antonara S, Coburn J (2011) The Borrelia burgdorferi integrin ligand P66 affects gene expression by human cells in culture. Infect Immun 79: 3249–3261.
[51]
Radolf JD, Caimano MJ, Stevenson B, Hu LT (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10: 87–99.
[52]
Hajnicka V, Vancova-Stibraniova I, Slovak M, Kocakova P, Nuttall PA (2011) Ixodid tick salivary gland products target host wound healing growth factors. Int J Parasitol 41: 213–223.
[53]
Francischetti IM, Sa-Nunes A, Mans BJ, Santos IM, Ribeiro JM (2009) The role of saliva in tick feeding. Front Biosci 14: 2051–2088.
[54]
Barthold SW, Persing DH, Armstrong AL, Peeples RA (1991) Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol 139: 263–273.
[55]
Kern A, Collin E, Barthel C, Michel C, Jaulhac B, et al. (2011) Tick saliva represses innate immunity and cutaneous inflammation in a murine model of Lyme disease. Vector Borne Zoonotic Dis 11: 1343–1350.
[56]
Diegmann J, Junker K, Gerstmayer B, Bosio A, Hindermann W, et al. (2005) Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry. Eur J Cancer 41: 1794–1801.
[57]
Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116–5121.
[58]
Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374–378.
[59]
Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365–371.
